spiperone has been researched along with benperidol in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (85.71) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrews, PR; Craik, DJ; Martin, JL | 1 |
| Ablordeppey, SY; Bricker, BA; Etukala, JR; Eyunni, SV; Huang, XP; Kang, HJ; Ofori, E; Onyameh, EK; Roth, BL; Zhu, XY | 1 |
| Fowler, JS; Logan, J; Shiue, CY; Wolf, AP | 1 |
| Arnett, CD; Fowler, JS; Logan, J; Shiue, CY; Watanabe, M; Wolf, AP | 1 |
| Arnett, CD; Fowler, JS; Shiue, CY; Watanabe, M; Wolf, AP | 1 |
| Heiss, WD; Laufer, P; Moerlein, SM; Pawlik, G; Stöcklin, G; Wienhard, K | 1 |
| Maayani, S; Stollak, JS; Wilkinson, CW | 1 |
7 other study(ies) available for spiperone and benperidol
| Article | Year |
|---|---|
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
Development of CNS multi-receptor ligands: Modification of known D2 pharmacophores.
Topics: Animals; Dopamine Agents; Humans; Ligands; Proton Magnetic Resonance Spectroscopy; Receptors, Dopamine D2 | 2016 |
Kinetic modeling of receptor-ligand binding applied to positron emission tomographic studies with neuroleptic tracers.
Topics: Animals; Antipsychotic Agents; Benperidol; Butaclamol; Cerebellum; Corpus Striatum; Female; Fluorine; Haloperidol; Kinetics; Models, Biological; Papio; Radioisotopes; Receptors, Dopamine; Spiperone; Tomography, Emission-Computed | 1987 |
Comparison of three 18F-labeled butyrophenone neuroleptic drugs in the baboon using positron emission tomography.
Topics: Animals; Benperidol; Brain; Butaclamol; Butyrophenones; Female; Fluorine; Haloperidol; Isotope Labeling; Male; Papio; Radioisotopes; Rats; Spiperone; Time Factors; Tissue Distribution; Tomography, Emission-Computed | 1985 |
Syntheses and specific activity determinations of no-carrier-added (NCA) F-18-labeled butyrophenone neuroleptics--benperidol, haloperidol, spiroperidol, and pipamperone.
Topics: Antipsychotic Agents; Benperidol; Butyrophenones; Fluorine; Haloperidol; Isotope Labeling; Radioisotopes; Spiperone | 1985 |
Evaluation of 75Br-labelled butyrophenone neuroleptics for imaging cerebral dopaminergic receptor areas using positron emission tomography.
Topics: Animals; Antipsychotic Agents; Benperidol; Brain; Bromine; Cerebellum; Female; Haloperidol; Radioisotopes; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone; Tomography, Emission-Computed | 1986 |
5-Hydroxytryptamine receptor in rabbit aorta: characterization by butyrophenone analogs.
Topics: Animals; Aorta; Azaperone; Benperidol; Butyrophenones; Haloperidol; In Vitro Techniques; Male; Rabbits; Receptors, Serotonin; Serotonin; Spiperone; Spiro Compounds; Structure-Activity Relationship | 1984 |